DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution
Showing posts with label LULICONAZOLE. Show all posts
Showing posts with label LULICONAZOLE. Show all posts

Wednesday, 10 February 2016

LULICONAZOLE NMR MASS

1H NMR DMSOD6

Luliconazole
Luliconazole.svg
Luliconazole ball-and-stick model.png
Systematic (IUPAC) name
(2E)-[(4R)-4-(2,4-Dichlorophenyl)-1,3-dithiolan-2-ylidene](1H-imidazol-1-yl)acetonitrile
Clinical data
Trade namesLuzu, Lulicon
Legal status
  •  (Prescription only)
Routes of
administration
Topical
Pharmacokinetic data
Protein binding>99%[1]
Identifiers
CAS Number187164-19-8
ATC codeD01AC18
PubChemCID 3003141
ChemSpider2273807
Chemical data
FormulaC14H9Cl2N3S2
Molar mass354.28 g/mol
Luliconazole (trade names Luzu, Lulicon) is an imidazole antifungal drug. As a 1% topical cream, It is indicated for the treatment of athlete's foot, jock itch, and ringworm caused by dermatophytes such as Trichophyton rubrum, Microsporum gypseum[2] andEpidermophyton floccosum.[1]

References

  1. ^ Jump up to:a b "LUZU (luliconazole) Cream, 1%. Full Prescribing Information." (PDF). Valeant Pharmaceuticals North America LLC. Retrieved1 October 2015.
  2. Jump up^ "FDA approves luliconazole for tinea pedis". November 19, 2013. Retrieved 14 January 2014.

External links






HR MS


1H NMR


/////////////
 C1[C@H](S/C(=C(\C#N)/N2C=CN=C2)/S1)C3=C(C=C(C=C3)Cl)Cl